Machine Learning-Based Pathomics Signature in Predicting MSH2 Expression and Prognosis in Gastric Cancer.

Key Points

• This research aims to explore how a machine learning-based pathomics signature can predict MSH2 expression and its prognostic implications in gastric cancer.
• Utilized machine learning techniques to analyze pathomics signatures.
• Focused on the relationship between pathomics data and MSH2 expression levels.
• Employed statistical analyses to assess the predictive power of the model.
• The machine learning-derived pathomics signature accurately predicts MSH2 expression levels.
• The findings suggest that this approach can provide valuable prognostic information for patients with gastric cancer.